Patent Prosecution Explained: Office Actions, Responses, and Strategy

Patent prosecution is the exchange between an applicant and the USPTO examiner that determines whether, and with what claims, an application becomes a patent. Most applications receive at least one rejection, and a rejection is a normal part of the process rather than a verdict. What matters is how each office action is read, which response strategy is chosen, and what is said on the record, because the claims that issue and the statements made to get them both shape what the patent will be worth.

This article is written from the perspective of a former examiner, for founders, engineering leaders, and in-house teams who want to understand what happens after filing.

What an office action contains

An office action is the examiner’s written evaluation of the claims. It usually includes:

• Rejections, which address whether claims are patentable
• Objections, which address form, such as informalities in the claims, drawings, or specification
• The references the examiner relies on, usually earlier patents and publications
• A deadline for responding

Office actions are designated non-final or final. A non-final action allows the applicant to amend the claims and argue freely. A final action limits what can be done as a matter of right, as described below.

The most common rejections

Anticipation (35 U.S.C. 102). The examiner asserts that a single prior art reference discloses every element of the claim.

Obviousness (35 U.S.C. 103). The examiner asserts that the claimed invention would have been obvious to a person of ordinary skill in the field, usually by combining two or more references. This is the most common type of prior art rejection.

Written description, enablement, and definiteness (35 U.S.C. 112). The examiner asserts that the specification does not adequately support or enable the claims, or that claim terms are unclear.

Subject matter eligibility (35 U.S.C. 101). Common for software, AI, and business method claims. The examiner asserts that the claims are directed to an abstract idea or other judicial exception without significantly more. USPTO guidance in this area changes periodically.

Double patenting. Statutory double patenting arises when two applications or patents claim the same invention, and it cannot be overcome with a terminal disclaimer. Nonstatutory, or obviousness-type, double patenting arises when commonly owned claims are not patentably distinct from one another, and it is often resolved with a terminal disclaimer, though not always: a disclaimer is not available for every conflict, and arguing that the claims are patentably distinct, or amending them, can be the better course. A terminal disclaimer has lasting consequences: the later patent’s term is limited to that of the earlier one, and the patents generally must remain commonly owned to stay enforceable. Those effects can matter in later licensing and sales (MPEP 804).

How examiners read claims

During examination, claims are given their broadest reasonable interpretation consistent with the specification (MPEP 2111). In practice, examiners read claim language as broadly as the words and the specification reasonably allow, which is often broader than the applicant intended.

Many disagreements in prosecution come from this difference. A claim term the inventors understand narrowly may be read broadly by the examiner, bringing in prior art that seems unrelated. Responses that address the interpretation directly, by pointing to how the specification uses the term or by amending to make the intended meaning explicit, tend to be more effective than responses that only argue the references.

Response options

A response must address every rejection and objection. The main tools are:

Argument. Explaining why the examiner’s reading of the references or the claims is incorrect, for example, that a reference does not actually disclose an element, or that there was no reason to combine the references as proposed.

Amendment. Changing the claims to distinguish the prior art. Every amendment must be supported by the application as filed, since new matter cannot be added. Amendments are where a well-drafted specification pays off: detailed embodiments and alternatives give more options for amendments that are both distinguishing and commercially meaningful.

Evidence. Declarations under 37 C.F.R. 1.132 can provide evidence, such as test results or unexpected results, to support arguments about patentability.

New claims. A response can add claims with different scope, as long as they are supported by the specification.

The examiner interview

An interview, by phone or video, is often the most efficient step in prosecution. It allows the applicant’s representative to explain the invention, understand the examiner’s actual concerns, and discuss proposed amendments before filing a formal response.

From the examiner’s side, an interview with a clear agenda and specific proposals is easier to engage with than a general discussion. A short written agenda sent in advance, identifying the claims, the references, and the proposed amendments or arguments, makes the conversation productive. Interviews frequently narrow the issues to a point where the next response leads to allowance.

Deadlines and extensions

For most office actions, a response is due within a shortened statutory period, commonly three months. That period can often be extended in one-month increments for fees, up to the six-month statutory limit (35 U.S.C. 133; 37 C.F.R. 1.136(a)). Not every USPTO communication follows that pattern, though: some periods differ, and some deadlines, such as the issue fee deadline, cannot be extended. Missing a deadline can result in abandonment, which can sometimes be revived but should never be relied on. These dates are docketed from the day a communication arrives.

After a final rejection

After a final rejection, amendments are no longer entered as a matter of right. Common options include:

• A request for continued examination (RCE), which reopens prosecution in the same application so that amendments and arguments are considered, for a fee
• An appeal to the Patent Trial and Appeal Board, when the disagreement is about the law or the reading of the references and further amendment would give up too much
• A continuation application, sometimes combined with accepting allowable claims in the current application
• Limited after-final responses, such as amendments that place the application in condition for allowance

The right choice depends on how close the claims are to allowance, how important the remaining scope is, and the cost and time of each path.

What you say on the record matters

Everything said and every amendment made during prosecution becomes part of the public prosecution history. Later, in litigation or licensing, that history can be used to interpret the claims and can limit their scope, including by restricting the doctrine of equivalents.

For that reason, effective prosecution says what is needed to overcome a rejection and no more. Broad characterizations of the invention, unnecessary concessions about the prior art, and amendments larger than needed can each narrow the patent in ways that are hard to undo.

Keeping options open

Prosecution decisions interact with the rest of the portfolio. Accepting narrower claims to get a patent issued quickly, while filing a continuation to pursue broader claims, is a common strategy. So is keeping a family pending so that claims can later be directed at competitors’ products. Both depend on filing continuations before the parent application issues.

A practical takeaway

Treat each office action as a negotiation with a defined record, not a judgment on the invention. Ask your patent attorney or agent how they read the examiner’s position, whether an interview would help, and how each proposed amendment affects the coverage that matters commercially. The goal is claims that issue and are still worth having when they do.